MedPath

Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells

Phase 1
Recruiting
Conditions
Multiple Sclerosis.
Multiple sclerosis
Registration Number
IRCT20161212031362N3
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria

McDonald's 2017 diagnostic criteria for multiple sclerosis

Exclusion Criteria

Any history of severe disease that interferes with study results, such as cancer, severe kidney disease, liver disease, digestive disease, heart disease, or any uncontrolled disease
Cognitive Disorder, Inability in fill out the consent form voluntarily

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath